Finance

Lists
HIMS:NYSE
Hims & Hers Health Inc
28,98 US$
-1,09%
(-0,32) 1D
2 ოქტ, 13:07:15 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for HIMS...
Open
30,08 US$
High
30,61 US$
Low
28,55 US$
Mkt. cap
6,76 მლრდ.
Avg. vol.
10,34 მლნ.
Volume
5,89 მლნ.
52-wk high
65,30 US$
52-wk low
13,74 US$
EPS
-0,63 US$
Beta
2,44
Shares outstanding
224,94 მლნ.
No. of employees
2 ათ.
Open
30,08 US$
High
30,61 US$
Low
28,55 US$
Mkt. cap
6,76 მლრდ.
Avg. vol.
10,34 მლნ.
Volume
5,89 მლნ.
52-wk high
65,30 US$
52-wk low
13,74 US$
EPS
-0,63 US$
Beta
2,44
Shares outstanding
224,94 მლნ.
No. of employees
2 ათ.
News stories
From web sources and news partners
Profile
Hims & Hers Health, Inc., doing business as hims, is an American telehealth company headquartered in San Francisco. It provides prescription medications, over-the-counter medications, and personal care products through a direct-to-consumer subscription model. Wikipedia
About Hims & Hers Health Inc
CEO-
Employees2,44 ათ.
Foundedნოე 2017
Headquartersსან-ფრანცისკო, კალიფორნია, ამერიკის შეერთებული შტატები
SectorHealth care provider
Websitehims.com
Analyst ratings
Based on 14 analysts giving stock ratings to HIMS in the past 3 months
Hold
Buy
3
Hold
11
Sell
0
12-month forecast
Based on 14 Wall Street analysts offering 12 month price targets for HIMS in the last 3 months.
Highest
Current 28,98 US$
42,00 US$ (+44,93%)
Average
32,82 US$ (+13,25%)
Lowest
26,00 US$ (-10,28%)
Analyst
Recommendation
Action
Price target
Projected
Date
Allen Lutz
Bank of America Securities
Hold
Reiterated
32,00 US$
+10,4%
09/25/2026
Jailendra Singh
Truist Financial
Hold
Reiterated
32,00 US$
+10,4%
09/11/2026
Bryan Smilek
J.P. Morgan
Hold
Initiated
32,00 US$
+10,4%
09/11/2026
Brian Tanquilut
Jefferies
Hold
Maintained
31,00 US$
+7%
09/03/2026
Justin Patterson
KeyBanc
Hold
Maintained
-
-
09/02/2026
Glen Santangelo
Barclays
Buy
Reiterated
35,00 US$
+20,8%
08/20/2026
George Hill
Deutsche Bank
Hold
Reiterated
26,00 US$
-10,3%
08/11/2026
Jonna Kim
TD Cowen
Hold
Reiterated
30,00 US$
+3,5%
08/11/2026
Craig Hettenbach
Morgan Stanley
Hold
Reiterated
28,00 US$
-3,4%
08/11/2026
Maria Ripps
Canaccord Genuity
Buy
Reiterated
40,00 US$
+38%
08/11/2026
Ryan MacDonald
Needham
Buy
Reiterated
42,00 US$
+44,9%
08/11/2026
David Larsen
BTIG
Hold
Reiterated
-
-
08/11/2026
Daniel Grosslight
Citi
Hold
Maintained
33,00 US$
+13,9%
08/12/2026
Mark Mahaney
Evercore ISI
Hold
Maintained
-
-
08/11/2026
Oliver Chen
TD Cowen
Hold
Reiterated
25,00 US$
-13,7%
05/12/2026
Cory Carpenter
J.P. Morgan
Buy
Maintained
33,00 US$
+13,9%
05/12/2026
Michael Cherny
Leerink Partners
Hold
Maintained
-
-
04/16/2026
Unknown Analyst
Nephron
Buy
Upgraded
35,00 US$
+20,8%
03/09/2026
Last report
10 აგვ. 2026
Fiscal period
Q2 2026
EPS / Est. (USD)
-0,09 US$ / 0,09 US$
-198,22%miss
Revenue / Est. (USD)
753,21 მლნ. / 730,12 მლნ.
+3,16%beat
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
598,98 მლნ.
617,82 მლნ.
608,10 მლნ.
753,21 მლნ.
Cost of goods sold
156,92 მლნ.
173,38 მლნ.
182,82 მლნ.
272,41 მლნ.
Cost of revenue
156,92 მლნ.
173,38 მლნ.
182,82 მლნ.
272,41 მლნ.
Research and development expenses
40,58 მლნ.
40,96 მლნ.
46,94 მლნ.
54,90 მლნ.
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
389,67 მლნ.
386,64 მლნ.
426,37 მლნ.
521,95 მლნ.
Operating expense
430,25 მლნ.
427,60 მლნ.
473,31 მლნ.
576,85 მლნ.
Total operating expenses
587,17 მლნ.
600,99 მლნ.
656,13 მლნ.
849,26 მლნ.
Operating income
11,81 მლნ.
16,83 მლნ.
-48,02 მლნ.
-96,04 მლნ.
Other non operating income
-5,99 მლნ.
-575,00 ათ.
-18,58 მლნ.
-2,43 მლნ.
EBT including unusual items
12,22 მლნ.
18,35 მლნ.
-101,55 მლნ.
-92,63 მლნ.
EBT excluding unusual items
12,22 მლნ.
21,56 მლნ.
-61,57 მლნ.
-96,22 მლნ.
Income tax expense
-3,55 მლნ.
-2,25 მლნ.
-9,44 მლნ.
-6,34 მლნ.
Effective tax rate
-29,05%
-12,25%
9,29%
6,85%
Other operating expenses
-
-
-
-
Net income
15,77 მლნ.
20,60 მლნ.
-92,12 მლნ.
-86,29 მლნ.
Net profit margin
2,63%
3,33%
-15,15%
-11,46%
Earnings per share
0,28
0,22
-0,19
-0,09
Interest and investment income
8,01 მლნ.
6,80 მლნ.
7,90 მლნ.
6,00 მლნ.
Interest expense
-1,60 მლნ.
-1,50 მლნ.
-2,87 მლნ.
-3,75 მლნ.
Net interest expenses
6,41 მლნ.
5,30 მლნ.
5,03 მლნ.
2,25 მლნ.
Depreciation and amortization charges
-
-
-
-
EBITDA
29,48 მლნ.
34,92 მლნ.
-26,07 მლნ.
-66,57 მლნ.
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google აპები